Trial intelligence / Profile preview

Baloxavir vs Oseltamivir for Influenza Outbreak Management in Nursing Homes

NCT05012189Phase 4Unknown

Sponsor
Insight Therapeutics
Start
Aug 2021
Primary completion
Dec 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of baloxavir marboxil in influenza, sponsored by Insight Therapeutics. Status: unknown.

02

Drugs

baloxavir marboxil
03

Conditions

influenza

Beyond the preview

Go deeper on NCT05012189.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05012189.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call